336 related articles for article (PubMed ID: 26365548)
1. Irreversible Electroporation of Hepatic and Pancreatic Malignancies: Radiologic-Pathologic Correlation.
Gonzalez-Beicos A; Venkat S; Songrug T; Poveda J; Garcia-Buitrago M; Poozhikunnath Mohan P; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):176-82. PubMed ID: 26365548
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation for Colorectal Liver Metastases.
Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
[TBL] [Abstract][Full Text] [Related]
3. Niche Applications of Irreversible Electroporation.
Bhatia SS; Arya R; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol.
Venkat S; Hosein PJ; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):153-8. PubMed ID: 26365545
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
Lencioni R; Crocetti L; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
[TBL] [Abstract][Full Text] [Related]
6. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
[TBL] [Abstract][Full Text] [Related]
7. Introduction to Irreversible Electroporation--Principles and Techniques.
Thomson KR; Kavnoudias H; Neal RE
Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
[TBL] [Abstract][Full Text] [Related]
8. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
9. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
[TBL] [Abstract][Full Text] [Related]
10. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
12. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
13. SI: Irreversible Electroporation (IRE). Introduction.
Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):127. PubMed ID: 26365540
[No Abstract] [Full Text] [Related]
14. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
[TBL] [Abstract][Full Text] [Related]
15. Focal Therapy of Prostate Cancer Using Irreversible Electroporation.
Valerio M; Ahmed HU; Emberton M
Tech Vasc Interv Radiol; 2015 Sep; 18(3):147-52. PubMed ID: 26365544
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
[TBL] [Abstract][Full Text] [Related]
17. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
[TBL] [Abstract][Full Text] [Related]
19. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
Wu LM; Zhang LL; Chen XH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
